This move is archived. Current quotes and coverage live on the stock page.
Get APTX alerts:
Apotex Health Corp stock has surged by 4.73% in the last trading session, reflecting a positive market sentiment.
In the latest trading session, Apotex Health Corp (APTX.TO) saw its stock price rise to CA$28.80, marking a notable increase of 4.73%. This uptick comes on the heels of the company's recent listing on the Toronto Stock Exchange, which has drawn attention to its robust portfolio of health products.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.62B
52W high
$40.18
52W low
$26.05
1W change
+1.00%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 24.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.34
+24.0% Upside
Current Price
C$33.35
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
30.3%
Annualized
90-Day Vol
46.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$39.87
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$35.40 | C$31.88 โ C$39.29 |
| 60 trading days | C$37.57 | C$32.41 โ C$43.55 |
| 90 trading days | C$39.87 | C$33.27 โ C$47.78 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are responding positively to Apotex's market debut and its commitment to providing affordable healthcare solutions, making it a stock to watch.
4.73% Increase in Stock Price
Apotex Health Corp's stock price rose to CA$28.80, reflecting investor optimism following its new listing.
Bull case
The recent market opening shows that Apotex is in a strong position within the pharmaceutical industry. This could lead to more growth and increased confidence from investors.
Bear case
Despite the positive movement, potential investors should keep in mind the competitive landscape of the pharmaceutical sector, which may present challenges for sustained growth.
Advertisement
Market Debut Sparks Investor Interest
Apotex Health Corp's recent listing on the Toronto Stock Exchange has generated significant buzz among investors. The company's commitment to providing affordable and innovative health products resonates well in today's market, where healthcare accessibility is a key concern.
Financial Performance and Future Outlook
With a P/E ratio of 17.86 and a market cap of over CA$6.66 billion, Apotex demonstrates solid financial health. Investors are optimistic about the company's growth trajectory, especially given its extensive portfolio of generic and branded pharmaceuticals. However, the competitive landscape remains a crucial factor to monitor.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
